Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?

Spinal cord injury (SCI) is a worldwide highly crippling disease that can lead to the loss of motor and sensory neurons. Among the most promising therapies, there are new techniques of tissue engineering based on stem cells that promote neuronal regeneration. Among the different types of stem cells,...

Full description

Bibliographic Details
Main Authors: Santino Blando, Ivan Anchesi, Emanuela Mazzon, Agnese Gugliandolo
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/14/7545
_version_ 1797433555962298368
author Santino Blando
Ivan Anchesi
Emanuela Mazzon
Agnese Gugliandolo
author_facet Santino Blando
Ivan Anchesi
Emanuela Mazzon
Agnese Gugliandolo
author_sort Santino Blando
collection DOAJ
description Spinal cord injury (SCI) is a worldwide highly crippling disease that can lead to the loss of motor and sensory neurons. Among the most promising therapies, there are new techniques of tissue engineering based on stem cells that promote neuronal regeneration. Among the different types of stem cells, mesenchymal stem cells (MSCs) seem the most promising. Indeed, MSCs are able to release trophic factors and to differentiate into the cell types that can be found in the spinal cord. Currently, the most common procedure to insert cells in the lesion site is infusion. However, this causes a low rate of survival and engraftment in the lesion site. For these reasons, tissue engineering is focusing on bioresorbable scaffolds to help the cells to stay in situ. Scaffolds do not only have a passive role but become fundamental for the trophic support of cells and the promotion of neuroregeneration. More and more types of materials are being studied as scaffolds to decrease inflammation and increase the engraftment as well as the survival of the cells. Our review aims to highlight how the use of scaffolds made from biomaterials enriched with MSCs gives positive results in in vivo SCI models as well as the first evidence obtained in clinical trials.
first_indexed 2024-03-09T10:18:40Z
format Article
id doaj.art-bf9a38e6c3884ee396a5958f6ce8784f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:18:40Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bf9a38e6c3884ee396a5958f6ce8784f2023-12-01T22:13:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-07-012314754510.3390/ijms23147545Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?Santino Blando0Ivan Anchesi1Emanuela Mazzon2Agnese Gugliandolo3IRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, ItalySpinal cord injury (SCI) is a worldwide highly crippling disease that can lead to the loss of motor and sensory neurons. Among the most promising therapies, there are new techniques of tissue engineering based on stem cells that promote neuronal regeneration. Among the different types of stem cells, mesenchymal stem cells (MSCs) seem the most promising. Indeed, MSCs are able to release trophic factors and to differentiate into the cell types that can be found in the spinal cord. Currently, the most common procedure to insert cells in the lesion site is infusion. However, this causes a low rate of survival and engraftment in the lesion site. For these reasons, tissue engineering is focusing on bioresorbable scaffolds to help the cells to stay in situ. Scaffolds do not only have a passive role but become fundamental for the trophic support of cells and the promotion of neuroregeneration. More and more types of materials are being studied as scaffolds to decrease inflammation and increase the engraftment as well as the survival of the cells. Our review aims to highlight how the use of scaffolds made from biomaterials enriched with MSCs gives positive results in in vivo SCI models as well as the first evidence obtained in clinical trials.https://www.mdpi.com/1422-0067/23/14/7545spinal cord injurymesenchymal stem cellscaffoldfibrincollagenchitosan
spellingShingle Santino Blando
Ivan Anchesi
Emanuela Mazzon
Agnese Gugliandolo
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
International Journal of Molecular Sciences
spinal cord injury
mesenchymal stem cell
scaffold
fibrin
collagen
chitosan
title Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
title_full Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
title_fullStr Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
title_full_unstemmed Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
title_short Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
title_sort can a scaffold enriched with mesenchymal stem cells be a good treatment for spinal cord injury
topic spinal cord injury
mesenchymal stem cell
scaffold
fibrin
collagen
chitosan
url https://www.mdpi.com/1422-0067/23/14/7545
work_keys_str_mv AT santinoblando canascaffoldenrichedwithmesenchymalstemcellsbeagoodtreatmentforspinalcordinjury
AT ivananchesi canascaffoldenrichedwithmesenchymalstemcellsbeagoodtreatmentforspinalcordinjury
AT emanuelamazzon canascaffoldenrichedwithmesenchymalstemcellsbeagoodtreatmentforspinalcordinjury
AT agnesegugliandolo canascaffoldenrichedwithmesenchymalstemcellsbeagoodtreatmentforspinalcordinjury